Reduction in drug resistance seen with reduced antibiotic use Newsletter Article 15 February 2013 Pages: 5 - 5
Model for predicting mortality in meningococcal disease Newsletter Article 15 February 2013 Pages: 5 - 5
LMWH use an ‘important advance’ in acute coronary syndromes Newsletter Article 15 February 2013 Pages: 6 - 6
Risperidone cost effective for improving QOL in schizophrenia Newsletter Article 15 February 2013 Pages: 7 - 7
Pramlintide improves metabolic control in diabetes mellitus Newsletter Article 15 February 2013 Pages: 9 - 9
PTCA superior to medical therapy for angina pectoris? Newsletter Article 15 February 2013 Pages: 10 - 10
Epilepsy: clinical questions and clinical outcomes Heather Langtry Newsletter Article 15 February 2013 Pages: 11 - 12
‘Promising’ second-line strategy in metastatic bladder cancer Newsletter Article 15 February 2013 Pages: 12 - 12
Antenatal phenobarbital does not prevent neonatal ICH Newsletter Article 15 February 2013 Pages: 13 - 13
Antiretroviral treatment affects HIV-1 levels in semen Newsletter Article 15 February 2013 Pages: 14 - 14
Streptokinase vs alteplase for massive pulmonary embolism Newsletter Article 15 February 2013 Pages: 15 - 15
Minocycline: no effect on radiographic progression in RA? Newsletter Article 15 February 2013 Pages: 16 - 16
Ganciclovir + aciclovir prevents CMV disease post-liver transplant Newsletter Article 15 February 2013 Pages: 16 - 16
Do all patients with inferior MI benefit from thrombolysis? Newsletter Article 15 February 2013 Pages: 17 - 17
Long-term HRT after menopause reduces arterial stiffness Newsletter Article 15 February 2013 Pages: 18 - 18
Antihypertensives and endothelininduced vasopressor responses Newsletter Article 15 February 2013 Pages: 19 - 19
No association between moderate vitamin A doses and teratogenicity Newsletter Article 15 February 2013 Pages: 19 - 19
Electronic ADR reporting is the way of the future Pauline Curel Newsletter Article 15 February 2013 Pages: 20 - 21
Oral challenges useful to predict long-term NSAID tolerance Newsletter Article 15 February 2013 Pages: 21 - 21
Hylan-G-F-20: US marketing approval for osteoarthritis Newsletter Article 15 February 2013 Pages: 22 - 22